RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
RIVANNA has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
RIVANNA's investors include National Science Foundation, National Institutes of Health, Biomedical Advanced Research and Development Authority (BARDA), National Cancer Institute, Congressionally Directed Medical Research Programs.
RIVANNA is headquartered in Crozet, United States.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
RIVANNA is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RIVANNA — Funding & Investors." VCBacked, October 21, 2025, https://www.vcbacked.co/company/rivanna. Accessed October 17, 2026.
VCBacked. (2025). RIVANNA — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/rivanna
{{cite web |title=RIVANNA — Funding & Investors |url=https://www.vcbacked.co/company/rivanna |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated